Presentation at the Global Maternal Newborn Health Conference, October 21, 2015
Background: Madagascar has a high maternal and neonatal mortality rate (478 per 100,000 live births and 21 per 1,000 live births respectively (WHO, 2013), with postpartum…
Presentation at the Global Maternal Newborn Health Conference, October 21, 2015
Background: The Millennium Development Goals (MDGs) did not include any equity focus, yet for many regions of the developing world and sub-Saharan Africa in particular,…
Presentation at the Global Maternal Newborn Health Conference, October 21, 2015
Background: SMGL undertook community-based activities in Uganda and Zambia to educate and engage families and community influentials, improve self-care, increase demand for…
Presentation at the Global Maternal Newborn Health Conference, October 21, 2015
Background: HIV/AIDS is the leading cause of death among women of reproductive age globally. Pregnant or postpartum women living with HIV have an estimated eight times…
Presentation at the Global Maternal Newborn Health Conference, October 20, 2015
Background: Traditional birth attendants (TBAs) are crucial, under-utilized resources for community-based maternal and newborn health (MNH) care, however are commonly…
Presentation at the Global Maternal Newborn Health Conference, October 20, 2015
Sub-national procurement of essential medicines is common in many countries where weak centralized systems cannot ensure access to essential medicines at service delivery…
Presentation at the Global Maternal Newborn Health Conference, October 20, 2015
Background: The BetterBirth Program is testing the impact of a WHO Safe Childbirth Checklist (SCC) based coaching intervention on maternal and neonatal outcomes in Uttar…
Presentation at the Global Maternal Newborn Health Conference, October 20, 2015
Background: As the deadline nears, many countries are still struggling to scale-up interventions in pursuit of Millennium Development Goals (MDGs) 4 and 5. While we know…
Presentation at the Global Maternal Newborn Health Conference, October 20, 2015
Background: Despite the evidence that magnesium sulfate ( MgSO4) is the drug of choice for managing severe pre-eclampsia and eclampsia (SPE/E), its usage seems low in limited…